|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltzand Olumiant for immunology. |
| 公司地址
| Lilly Corporate Center, Indianapolis, IN, USA, 46285 |
| 電話號碼
| +1 317 276-2000 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lilly.com |
| 員工數量
| 50000 |
| Mr. Lucas Montarce |
Executive Vice President and Chief Financial Officer |
美元 664.64K |
12/02/2026 |
| Mr. David A. Ricks |
Chairman of the Board, President and Chief Executive Officer |
美元 1.69M |
12/02/2026 |
| Mr. Donald A. Zakrowski |
Senior Vice President, Finance and Chief Accounting Officer |
-- |
12/02/2026 |
| Mr. Jacob S. Van Naarden |
Executive Vice President, President, Lilly Oncology and Head of Corporate Business Development |
美元 890.39K |
12/02/2026 |
| Ms. Adrienne S Brown |
Executive Vice President and President, Lilly Immunology |
-- |
12/02/2026 |
| Ms. Anat Hakim |
Executive Vice President, General Counsel and Secretary |
美元 1.00M |
12/02/2026 |
| Mr. Eric Dozier |
Executive Vice President and Chief People Officer |
-- |
12/02/2026 |
| Dr. Daniel M. Skovronsky, M.D.,PhD |
Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Laboratories |
美元 1.43M |
12/02/2026 |
| Mr. Patrik Jonsson |
Executive Vice President and President, Lilly International |
-- |
12/02/2026 |
| Mr. Ilya Yuffa |
Executive Vice President and President, Lilly USA and Global Customer Capabilities |
-- |
12/02/2026 |
| Dr. Kenneth L. Custer, PhD |
Executive Vice President and President, Lilly Cardiometabolic Health |
-- |
12/02/2026 |
| Ms. Melissa Seymour |
Executive Vice President, Global Quality |
-- |
12/02/2026 |
| Mr. Edgardo Hernandez |
Executive Vice President and President, Manufacturing Operations |
-- |
12/02/2026 |
| Mr. Diogo Rau |
Executive Vice President, Chief Information Officer and Chief Digital Officer |
-- |
12/02/2026 |
| Dr. Carole Ho, M.D. |
Executive Vice President and President, Lilly Neuroscience |
-- |
12/02/2026 |
|
|
| Ms. Gabrielle Sulzberger, J.D.,M.B.A. |
Independent Director |
12/02/2026 |
| Mr. Jon Erik Fyrwald |
Independent Director |
12/02/2026 |
| Mr. Jon R. Moeller |
Independent Director |
12/02/2026 |
| Mr. Juan R. Luciano |
Lead Independent Director |
12/02/2026 |
| Dr. Mary Lynne Hedley,PhD |
Independent Director |
12/02/2026 |
| Dr. Carolyn R. Bertozzi, PhD |
Independent Director |
12/02/2026 |
| Mr. Ralph Alvarez |
Independent Director |
12/02/2026 |
| Dr. Katherine Baicker, PhD |
Independent Director |
12/02/2026 |
| Mr. David A. Ricks |
Chairman of the Board, President and Chief Executive Officer |
12/02/2026 |
| Dr. William G. Kaelin, Jr,M.D. |
Independent Director |
12/02/2026 |
| Mr. Jamere Jackson |
Independent Director |
12/02/2026 |
| Ms. Kimberly H. Johnson |
Independent Director |
12/02/2026 |
|
|
|
|
